Precision approaches are driving innovation in disease-specific regenerative medicine, where therapies are designed to meet the distinct requirements of conditions like Parkinson’s, type 1 diabetes, and osteoarthritis. By targeting disease mechanisms, researchers employ tailored stem cell lines, responsive scaffolds, and signaling molecules to regenerate affected tissues more effectively. Integration of genetic profiling and cellular engineering enables treatments that address not only structural damage but also underlying pathophysiology. Disease-specific regenerative medicine brings personalized medicine closer to reality by aligning molecular pathology with regenerative tools. This targeted approach reduces risks of immune rejection and improves therapeutic efficacy, especially in chronic and degenerative conditions with limited treatment options.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Planar microorganoPit-based co-culture platform (MICA) for studying tumor-immune interactions in patient-derived tumoroids
Xiaochun Cao Ehlker, HTCR-Services GmbH, Martinsried/Planegg, Germany
Title : Comparing the effect of using calcified autogenous nano dentin particles versus micro dentin particles in the healing of mandibular bony defects in New Zealand rabbits
Sarah Yasser, Oral Biology Department, Faculty of Dentistry, Tanta University, Egypt
Title : Channel fidelity limits in in-wound hydrogel printing for cartilage regeneration
Evgenia Papadimitriou, AVT.CVT, RWTH University, Germany
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom